![]() |
|
|
Vol. 289, Issue 3, 1237-1244, June 1999
National Research Institute of Chinese Medicine, Taipei Taiwan, Republic of China (G.J.W., C.F.C., L.C.L.); Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China (Y.T.H.); and Department of Physiology, University of Alberta, Edmonton, Alberta, Canada (X.C.W., J.S., P.K.T.P.)
| |
Abstract |
|---|
|
|
|---|
Rutaecarpine (Rut) has been shown to induce hypotension and
vasorelaxation. In vitro studies indicated that the vasorelaxant effect
of Rut was largely endothelium-dependent. We previously reported that
Rut increased intracellular Ca2+ concentrations
([Ca2+]i) in cultured rat endothelial cells
(ECs) and decreased [Ca2+]i in
cultured rat vascular smooth muscle (VSMCs) cells. The present results
showed that the hypotensive effect of Rut (10-100 µg/kg i.v.) was
significantly blocked by the nitric oxide synthase inhibitor N
-nitro-L-arginine. In aortic rings, Rut
(0.1-3.0 µM)-induced vasorelaxation was inhibited by
N
-nitro-L-arginine and hydroquinone but
not by antagonists of the various K+ channels,
4-aminopyridine, apamin, charybdotoxin, or glibenclamide. Rut (0.1 and
1.0 µM) inhibited the norepinephrine-induced contraction generated by Ca2+ influx and at 1.0 µM increased cyclic
GMP (cGMP) production in endothelium-intact rings and to a lesser
extent in endothelium-denuded rings. In whole-cell patch-clamp
recording, nonvoltage-dependent Ca2+ channels were recorded
in ECs and Rut (0.1, 1.0 µM) elicited an opening of such channels.
However, in VSMCs, Rut (10.0 µM) inhibited significantly the L-type
voltage-dependent Ca2+ channels. In ECs cells, Rut (1.0, 10.0 µM) increased nitric oxide release in a
Ca2+-dependent manner. Taken together, the results
suggested that Rut lowered blood pressure by mainly activating the
endothelial Ca2+-nitric oxide-cGMP pathway to reduce smooth
muscle tone. Although the contribution seemed to be minor in nature,
inhibition of contractile response in VSMCs, as evidenced by inhibition
of Ca2+ currents, was also involved. Potassium channels, on
the other hand, had no apparent roles.
| |
Introduction |
|---|
|
|
|---|
Rutaecarpine
(Rut) is a quinazolinocarboline alkaloid isolated from a well known
Chinese herbal drug Wu-Chu-Yu, the dried, unripe fruit of Evodia
rutaecarpa (Juss) Benth. Pharmaceutical preparations based on
Wu-Chu-Yu have been widely used in China for hundreds of years to treat
gastrointestinal disorders, dysmenorrhea (Chang and But, 1986
), and
hypertension (Tang and Eisenbrand, 1992
). The reported biological
effects of Rut include diuresis, perspiration (Kametani, 1977
),
uterotonic action (King et al., 1980
), improvement in cerebral
functions (Yamahara et al., 1988
), vasorelaxation (Chiou et al., 1994
),
and antinociception (Matsuda et al., 1997
). Rut also inhibits
KCN-induced anoxia (Yamahara et al., 1989
), specific
2,3,7,8-tetrachlorodibenzo-p-dioxin binding (Gillner et al.,
1989
), cytochrome P-450 isozyme (Rannug et al., 1992
), and platelet
aggregation (Sheu et al., 1996
).
In a previous study (Wang et al., 1996
), we showed that Rut
lowered blood pressure in anesthetized rats and inhibited the tension
development induced by norepinephrine (NE) in rings from rat aortae
mainly in an endothelium-dependent manner, although the vasorelaxation
effect persisted in endothelium-denuded aorta, albeit to a much reduced
extent. Using the [Ca2+]i
detecting fura-2/AM
(1-[2-(5-carboxyoxazol-2-yl)-6-aminobenzofuran-5-oxy]-2-(2'-amino-5'-methylphenoxy)-ethane-N,N,N,N-tetraacetic acid pentaacetoxymethyl ester) technique, Rut was shown in the same
study to sustain an increase in
[Ca2+]i in cultured
endothelial cells (ECs) through activation of
Ca2+ influx, possibly via
Ca2+ channels. It was also found that Rut reduced
[Ca2+]i through the
inhibition of Ca2+ influx and
Ca2+ release from intracellular stores in
vascular smooth muscle cells (VSMCs), suggesting the inhibition of
Ca2+ channels. Thus, Rut was suggested to
regulate Ca2+ channels in ECs and VSMCs in
opposing manners in achieving vasorelaxation. As the definition of
Rut's actions on Ca2+ fluxes had been based on
indirect evidence, in the present study, characterization of the
biochemical mechanisms of Rut was augmented by direct assessment of
changes in Ca2+ channel activities in single
cultured rat aortic ECs and VSMCs using the whole-cell version of the
patch-clamp technique.
Nitric oxide (NO) generation has been implicated in the vasorelaxant
effect of Rut (Chiou et al., 1994
). To determine whether NO is involved
in Rut-induced decrease in mean arterial pressure (MAP) and
vasorelaxation, we investigated the influence of
N
-nitro-L-arginine (L-NNA), an NO synthase inhibitor (Wang et al.,
1993
), and hydroquinone, an NO inactivator (Moncada et al., 1986
), on
the effects of Rut in vivo and/or in vitro. Because the functional NO
synthase in the endothelium is believed to be constitutive and
Ca2+-dependent, we also measured Rut-induced NO
production in ECs under both normal Ca2+ and
Ca2+-free conditions by a sensitive
chemiluminescence technique. Evidence indicates that the NO-induced
vasorelaxation is a result of cGMP production (Rapoport and Murad,
1983
). To determine whether the Rut-induced vasorelaxation was because
of an increase in cGMP, the levels of cGMP were monitored.
Increases in [Ca2+]i
could also trigger the release of a K+
channel-activating endothelium-derived hyperpolarizing factor from the
ECs (Chen and Suzuki, 1990
). In addition, one possible mechanism of NO
or cGMP-induced vasorelaxation is the activation of
Ca2+-dependent K+
(KCa) channels (Archer et al., 1994
; Bolotina et
al., 1994
). Moreover, it is now well established that the opening of
K+ channels serves to hyperpolarize the cell
membrane and also interacts with Ca2+ channels in
the VSMC plasma membrane as well as intracellular Ca2+ release, leading to relaxation of vascular
smooth muscle (Kühberger et al., 1993
). To assess whether the
vasorelaxing effect of Rut was mediated by K+
channels, 4-aminopyridine, a specific inhibitor of voltage-dependent K+ (Kv) channels (Okabe et
al., 1987
), apamin, a specific blocker of the small conductance
KCa channels (Nakao et al., 1986
), charybdotoxin, a specific blocker of the large conductance KCa
channels (Gimenez-Gallego et al., 1988
), and glibenclamide, a specific
inhibitor of ATP-sensitive K+ channels (Quast and
Cook, 1989
) were used to define the possible mechanisms of action.
The results obtained show that the activation of the endothelial Ca2+-NO-cGMP cascade could largely account for the hypotensive and vasorelaxant actions of Rut. A minor direct Ca2+ influx inhibition, through both voltage-dependent Ca2+ channels (VDCCs) and receptor-operated Ca2+ channels (ROCCs), in VSMCs also seemed to be involved. In contrast, K+ channels seemed not to be involved.
| |
Materials and Methods |
|---|
|
|
|---|
Rats
Adult male Sprague-Dawley rats, weighing 200 to 250 g (Taconic Farms, Germantown, NY), were used. The rats were allowed to acclimate in environmentally controlled quarters with temperature maintained at 20-22°C, relative humidity 55%, and lighting with 12:12-h light/dark cycles. Standard laboratory chow (Purina Mills, Richmond, IN) and drinking water were provided ad libitum.
Blood Pressure Measurement
Rats were anesthetized i.p. with 50 mg/kg sodium pentobarbital and placed on a heating pad to maintain body temperature at 37°C. The right femoral artery was cannulated for the recording of arterial blood pressure with a Gould model 3400S polygraph (Gould, Valley View, OH) via a P23XL pressure transducer (Viggo-Spectramed, Oxnard, CA). Polyethylene catheters (PE-50; Clay Adams, Parsippany, NJ) were also inserted into both femoral veins for the administration of drugs. One venous catheter was used for bolus i.v. injection of Rut (10, 30, or 100 µg/kg). The second venous catheter was used for continuous infusion of saline or saline containing L-NNA (2.22 mg/kg/min) at a rate of 0.5 ml/min for 30 min before the administration of Rut and throughout the entire duration (45 min) of the experiment. Dose-dependent MAP changes in response to bolus i.v. injection of Rut was determined. The changes in MAP from nine rats given Rut in the presence of L-NNA were compared with those from another nine rats that received Rut at the same dose but without L-NNA.
In Vitro Vascular Tension Study
Another group of rats was sacrificed by decapitation. Sections
of the thoracic aortae between the aortic arch and the diaphragm were
excised carefully and fixed isometrically in organ chambers (15 ml)
containing a modified Krebs' solution: 120 mM NaCl, 4.5 mM KCl, 2.5 mM
CaCl2, 1 mM MgSO4, 27 mM
NaHCO3, 1 mM
KH2PO4, and 10 mM glucose
maintained at 37°C and through which a mixture of 95%
O2, 5% CO2 was bubbled.
The details of the preparation procedure have been described previously
(Wang et al., 1996
). Briefly, aortic rings of 3 to 4 mm in length were
equilibrated under passive tension of 1.0 g for 60 min. During
this time, the tissues were washed every 15 min. After equilibration,
the aortic rings were stabilized with a near maximal contraction
induced by phenylephrine (0.3 µM). After the rings achieved a stable
contractile tension, acetylcholine (1 µM) was added to the baths to
assess endothelial integrity. In some preparations, the intima was
gently frayed with a cotton swab to disrupt the endothelium. The
absence of acetylcholine-induced relaxation indicated that the vessels
were denuded successfully.
Effects of Inhibitors on the Rut-Induced Vasorelaxation
For the evaluation of relaxation, Rut (0.1-3.0 µM) was added in a cumulative manner during the tonic phase of contraction (considered as 100%) induced by phenylephrine (0.3 µM) in both endothelium-intact and -denuded aortic rings. Construction of concentration-response curves for Rut was based on percent of relaxation of the phenylephrine-induced contraction. To determine the contribution of endothelium-derived NO in the vasorelaxing effect of Rut, the endothelium-intact preparations were preincubated with L-NNA (100 µM) or hydroquinone (10 µM) for 10 min before phenylephrine-induced contraction. Then, the cumulative doses of Rut (0.1-3.0 µM) were applied during the sustained phase of contraction. To determine the contribution of K+ channels in the vasorelaxing effect of Rut, another group of endothelium-intact preparations was preincubated with various K+ channel blockers such as 4-aminopyridine (5 mM), apamin (0.1 µM), charybdotoxin (0.1 µM), or glibenclamide (1 µM) for an appropriate period (10-20 min) before phenylephrine-induced contraction. The concentration-response curves of Rut (0.1-3.0 µM) in the presence of various blockers were constructed as described above. To obtain similar control tension generation in the presence or absence of blocker, 0.1 or 3.0 µM phenylephrine, respectively, was used to induce contraction. The effects of the various blockers were studied by comparing the degrees of vasorelaxation induced by Rut in the absence and presence of those blockers. The dosages of the blockers used have been reported to be adequate to produce the necessary NO and K+ channel blockade.
Effects of Extracellular Ca2+ on Rut's Modulation of NE-Induced Contraction
To delineate the inhibition of extracellular
Ca2+ influx involved in Rut-induced relaxation,
after equilibration, the experiments were carried out in
Ca2+-free Krebs' solution. Addition of NE (0.1 µM) induced a transient vasocontraction, which was dependent on
intracellular stored Ca2+ release (Suematsu et
al., 1984
). As the NE-induced contraction reached a steady state,
cumulative concentrations of Ca2+ (0.1-3.0 mM)
were applied to permit the observation of the effects of a step-wise
increase in extracellular Ca2+ concentration. The
contraction by NE under such conditions was therefore the result of
Ca2+ influx from extracellular space. After
washing and equilibration for 30 min, the experiment was repeated in
the presence of Rut (0.1, 1.0 µM) or vehicle for 5 min. With the
maximal tension attained by vehicle at Ca2+ (3.0 mM) being considered as 100%, concentration-response curves for the
added Ca2+ were constructed and compared in
endothelium-intact and -denuded aortic rings.
cGMP Measurement
The method was essentially the same as reported previously
(Huang et al., 1995
). Aortic rings were isolated as described above. The tissues were incubated in Krebs' solution with Rut (1.0 µM) or
vehicle at 37°C for 10 min. The cyclic nucleotide phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (10 µM) was added during the
last 5 min of the incubation period. The reaction was stopped by
immersing the tissue in liquid nitrogen and storing at
80°C up to
the time of thawing in chilled 6% trichloroacetic acid. The thawed
tissues were homogenized and centrifuged at 10,000g for 5 min. The supernatant fractions were extracted four times with 5 volumes
of water-saturated diethyl ether, dried under a stream of nitrogen, and
assayed for cGMP content by radioimmunoassay (radioimmunoasay
kits from Amersham International PL, UK), and the precipitate was saved
for protein determination. The cGMP levels were expressed as pmol/mg protein.
In Vitro Whole-Cell Patch-Clamp Recording
Cell Culture.
Rat aortic ECs were prepared and identified as
previously described (Wang et al., 1996
). The standard maintenance
growth medium (minimum essential medium) was supplemented with 10%
fetal calf serum (FCS) and antibiotics. Single VSMCs were isolated by
collagenase-elastase dissociation from the rat thoracic aorta by using
previously published procedures developed in our laboratory (Wang et
al., 1996
). The cells were grown in Dulbecco's modified Eagle's
medium supplemented with 10% FCS and antibiotics. All growth was
carried out in a humidified incubator equilibrated with a 5%
CO2 atmosphere at 37°C. ECs exhibited typical
cobblestone appearance and expressed factor VIII antigen. Examination
by phase-contrast microscopy showed that VSMCs formed a hills and
valleys pattern at confluence, a well known characteristic of VSMCs in
culture. These cells contracted in response to NE (10 µM), indicating
that they were functional VSMCs. Before being used in studies, the
cells were incubated in trypsin-EDTA solution for 30 to 120 s,
washed with Hanks' balanced salt solution (HBSS), slightly agitated,
and divided into small groups ranging in number from 1 to 30 cells for
each dish. After dispersion, cells were allowed to reattach to the
culture dish. Only one experiment was conducted per dish. Cells were
used between passage 3 and 6 and within 10 to 24 h after they were
plated. The limited time after isolation helped to maximize
Ca2+ current amplitudes of the cells.
Solutions.
The extracellular solution used for recording
Ca2+ currents contained 20 mM
BaCl2, 5 mM KCl, 5 mM CsCl, 105 mM
Tris, 20 mM HEPES, 20 mM glucose, as well as 0.5 µM
tetradotoxin. The internal (pipette) solution consisted of 70 mM
Cs2-aspartate, 2 mM
ATP-Na2, 5 mM potassium-succinate, 5 mM
potassium-pyruvate, 5 mM MgCl2, 5 mM phosphocreatine-Na2, 15 mM HEPES, 10 mM EGTA, 25 mM glucose, and creatine phosphokinase at a concentration of 50 U/ml.
The pH and osmolarity of all solutions were adjusted to 7.4 and 320 mOsM, respectively. Calcium channel currents were isolated from
possible interference by Na+ currents by having
tetradotoxin added to Na+-free extracellular
solution while Kv and KCa
currents were eliminated by filling the detecting micropipette with
Cs+-containing solution, which was
introduced into the intracellular milieu upon breaking the cell
membrane by suction (Quandt and Narahashi, 1984
). Solutions were
filtered (0.22 µm) before use.
Electrophysiology.
Ca2+ channel
activity was determined in single ECs and VSMCs by the whole-cell
version of the patch-clamp technique (Hamill et al., 1981
). Whole-cell
Ca2+ current measurements were carried out using
an Axopatch-1C patch clamp amplifier (Axon Instruments, Foster City,
CA). Patch micropipettes were pulled and fire polished from
borosilicate glass capillaries (o.d., 1.2 mm; i.d., 0.9 mm; FHC,
Brunswick, ME) with a wall thickness of 0.3 mm. The tip diameter was
approximately 1 µm with a resistance range from 4 to 8 M
when
filled with pipette solution. Further application of suction via a tube
attached to the pipette holder permitted the formation of a gigaseal
and the harvesting of a patch membrane. In all experiments,
Ba2+ was used as the charge carrier. Because the
inward Ba2+ currents were small and the series
resistance was less than 0.1 ohms, series-resistance compensation was
not usually used. The currents were monitored using a digital
oscilloscope (Nicolet Instrument Corp., Madison, WI) and filtered at 1 kHz with a low pass filter (Axon Instruments). The software pCLAMP
and a labmaster interface (Axon Instruments) were used for the
generation of test pulses and storage and analysis of data. Leakage and
capacitive currents were subtracted during analysis. Simultaneously
slow records were taken on an SC 284 chart recorder (Gould, Valley View, OH). All recording was done at room temperature (20-22°C).
Effects of Rut on Ca2+ Channel Activity in ECs
Plastic Petri dishes containing cultured ECs were mounted on the
stage of an inverted microscope (IMT2; Olympus Corp., Lake Success,
NY). After establishing a tight seal (>5 G
) of the pipette tip with
ECs, the patch membrane was ruptured by negative current pulses. The
holding potential was
60 mV. After achieving whole-cell configuration, at least 10 min was allowed for equilibration to permit
voltage-dependent parameters of membrane conductance to stabilize. Rut
(0.1, 1.0 µM) or vehicle was added to a static bath to produce the
inward current in the absence of depolarizing pulses. In addition,
Ca2+ ionophore A23187 was applied to demonstrate
the implication of Ca2+ in the activation of the
inward current.
Effects of Rut on Ca2+ Channel Activity in VSMCs
To generate current-voltage (I-V) curves, the
Ba2+ current through the
Ca2+ channels was elicited by depolarizing the
VSMC from a test pulse of
30 mV to more positive test potentials at a
frequency of 0.1 Hz. The duration of the depolarizing test pulses was
250 ms at intervals of 5 s. Peak currents were used to construct
the I-V relationships. Only cells showing stable channel activity for at least 5 min were used to test the effect of Rut. The I-V
relationships were measured repeatedly for 5 min after the addition of
Rut (10.0 µM) or vehicle in the medium. At the end, Bay K 8644 (5 µM), a Ca2+ slow channel agonist, and
nifedipine (10 µM), a dihydropyridine Ca2+
channel blocker, were added to confirm that the inward currents recorded were carried almost exclusively by L-type
Ca2+ channels.
NO Measurement
ECs were grown in 35-mm2 dishes. Upon reaching confluence in about 4 days, the medium was changed to HBSS with L-arginine (100 µM) and added CaCl2 (to 2.5 mM). The changing over to HBSS was necessary because it provided the least interference in the assay. However, additional Ca2+ was required to make the final concentration comparable with that in normal Krebs' solution. The cells were then equilibrated for 60 min at 37°C. Aliquots of the supernatant were collected for analysis of nitrite by chemiluminescence (considered as 100%). Rut (1.0, 10.0 µM) or vehicle was then added for 10 min to stimulate NO release. The cell supernatants were also collected for analysis of nitrite. To study whether Rut-induced NO release was dependent on extracellular Ca2+, similar experiments also were carried out in Ca2+-free HBSS containing EGTA (2 mM). Samples (100 µl) containing nitrite were measured by adding a reducing agent (1% KI in glacial acetic acid) to the purge vessel to convert nitrite to NO, which was then carried by a flow of helium to the NO analyzer (model 280; Sievers Research Inc., Boulder, CO). Nitrite concentrations were calculated by comparison with standard solution of sodium nitrite. The number of cells in each dish was counted immediately by the 0.4% trypan blue exclusion method. The results, normalized to amount (picomoles) per 106 cells, were expressed as percentage of changes with basal NO content being 100%.
Drugs
The following drugs were used: Rut (mw 287.31) was isolated and
purified by the National Research Institute of Chinese Medicine (Taipei, Taiwan, Republic of China) (Lin et al., 1991
); acetylcholine, 4-aminopyridine, FCS, hydroquinone, 3-isobutyl-1-methylxanthine, NE,
nifedipine, L-NNA, phenylephrine, and sodium nitrite were purchased from Sigma Chemical Co. (St. Louis, MO); apamin and glibenclamide were purchased from RBI Research Biochemicals Co. (Natick, MA); Bay K 8644 was obtained from
Calbiochem-Novabiochem Corp. (La Jolla, CA); charybdotoxin was
purchased from Alomone Labs (Jerusalem, Israel); and Dulbecco's
modified Eagle's medium and minimum essential medium were purchased
from Life Technologies Inc. (Gaithersburg, MD). Apamin was dissolved in
0.05 M acetic acid. Bay K 8644, glibenclamide, and nifedipine were
dissolved in absolute ethanol. Charybdotoxin was dissolved in Krebs'
buffer. Other drugs were dissolved in distilled water and kept at
20°C, except Rut, which was dissolved in dimethyl sulfoxide and
ethanol mixture (2:8) to make 0.1 to 10 mM stock solutions. The final concentration of the vehicle in the solution did not exceed 0.1%, which had no effects on vascular tension, cGMP levels,
magnitude/kinetics of the inward current of ECs and VSMCs, or NO production.
Statistical Analysis
The data are presented as mean ± S.E., and n represents the number of experiments. In most cases, it was the peak inward current that was used for displays. Statistical analysis was made by Student's unpaired t test when applicable, P values less than 0.05 were considered to be significant.
| |
Results |
|---|
|
|
|---|
Antagonistic Effect of L-NNA on the Rut-Induced
Hypotension.
A 30-min infusion period of L-NNA
elevated MAP from the baseline level of 104 ± 4 mm Hg
progressively to 138 ± 4 mm Hg. This elevated MAP was sustained
throughout the entire period of the experiment. Normal saline infusion
did not significantly change the baseline MAP of 103 ± 4 mm Hg.
As Rut was dissolved in a mixture of dimethyl sulfoxide and ethanol
(2:8), the vehicle was first tested for possible effects on MAP. The
decrease in MAP of 8 ± 3 mm Hg was statistically not significant.
Consistent with a previous report (Wang et al., 1996
), i.v. injection
of Rut in anesthetized rats induced a decrease in MAP in a
dose-dependent manner (Fig. 1).
L-NNA infusion significantly attenuated the MAP-lowering
effects of the higher doses of Rut (Fig. 1).
|
Effects of Inhibitors on the Rut-Induced Vasorelaxation.
As
previously reported (Wang et al., 1996
), Fig.
2 shows that Rut (0.1-3.0 µM) caused a
concentration-dependent relaxation in phenylephrine-induced contraction
in endothelium-intact preparations. Pretreatment with L-NNA
or hydroquinone inhibited the Rut-induced vasorelaxation, suggesting
that NO was involved in Rut-induced vasorelaxation. Endothelium removal
significantly attenuated Rut-induced vasorelaxation so that only when
the concentration of Rut reached 3.0 µM was a significant decrease in
contractile tension observed. Figure 3
shows the failure of several K+ blockers
including 4-aminopyridine, apamin, charybdotoxin, or glibenclamide in
altering Rut-induced vasorelaxation in endothelium-intact aortic rings,
suggesting that K+ channels were not involved.
|
|
Effects of Extracellular Ca2+ on Rut's Modulation of
NE-Induced Contraction.
In Ca2+-free Krebs'
solution, NE induced only a transient contraction, and the
intracellular Ca2+ store was readily depleted. By
adding Ca2+ (0.1-3.0 mM) back to the bathing
buffer, NE induced a sustained contraction at levels that depended on
the concentration of the external Ca2+,
suggesting that Ca2+ influx was essential for the
NE-induced contraction. Figure 4 shows
that treatment with NE (0.1 µM) induced a
Ca2+-dependent contraction in endothelium-intact
aortic rings. When the aortic ring was treated with Rut at 0.1 or 1.0 µM 5 min before NE, the NE-induced contraction was attenuated,
suggesting that Ca2+ influx was probably
involved. To determine the role of the endothelium in Rut-induced
inhibition of Ca2+, similar experiments were
conducted on endothelium-denuded aortic rings. Treatment with Rut at
1.0 µM but not at 0.1 µM inhibited the contraction caused by NE in
buffers containing different concentrations of
Ca2+ (Fig. 5).
|
|
Effects of Rut on cGMP.
The basal cGMP levels in
endothelium-intact and -denuded aortic rings were 1.31 ± 0.17 and
0.32 ± 0.04 pmol/mg, respectively (Fig.
6). In endothelium-intact tissues,
treatment with Rut (1.0 µM) for 10 min significantly increased it 3- to 4-fold to 5.60 ± 0.38 pmol/mg, whereas vehicle treatment
resulted in an insignificant increase to 1.53 ± 0.39 pmol/mg. In
endothelium-denuded preparations, Rut induced a small but significant
accumulation of cGMP, whereas vehicle treatment had insignificant
effects (0.70 ± 0.22 versus 0.30 ± 0.05 pmol/mg protein).
|
Effects of Rut on Ca2+ Channel Activity in ECs.
With Ba2+ as the permeable extracellular ion, the
inward current averaged 5.60 ± 2.40 pA. The concentrations of Rut
chosen were 0.1 and 1.0 µM as they appeared to be in the linear
section of the concentration-relaxation curve, the relaxation induced
by 3.0 µM being considered maximal (Fig. 2). Figure
7 shows a typical recording of inward
currents during the application of Rut (0.1, 1.0 µM) or vehicle in
three different cells. The concentration dependence of the peak
amplitude of the Ca2+ current is plotted in Fig.
8. When the hyperpolarized ECs was treated with Rut (0.1 µM), a long-lasting inward current of up to 25 pA was observed, whereas vehicle alone had insignificant effect on the
current (4.48 ± 1.04 pA). The current reached a peak after about
10 s, remained at a steady current of 17.20 ± 6.88 pA for
19 s, and then returned to the holding potential. Rut (1.0 µM)
significantly increased the amplitude and caused a sustained increase
in Ca2+ currents to 34.72 ± 5.60 pA and
then declined over a period of 2 to 3 min in the continuing presence of
Rut. The average duration of the Ca2+ currents,
measured midway between the holding potential and peak negativity, was
35 s with Rut (1.0 µM).
|
|
Effects of Rut on Ca2+ Channel Activity in VSMCs.
VSMCs were depolarized from
30 to 60 mV with the ramp protocol to
investigate the channel openings. Ba2+ currents
through long-lasting L-type Ca2+ channels were
observed in VSMCs. During a 5-min application of vehicle alone, no
significant changes (
0.5 ± 1.2%) in the kinetics and I-V
relationship of L-channel current occurred (not shown). Figure
9 shows that a 5-min application of Rut
(10 µM) reduced the L-type current to below the immediately preceding
current measured in vehicle-treated specimen. The decrease in the
magnitude of L-channel currents induced by Rut was evident within 2 to
3 min and reached a steady-state level within 5 min. Figure
10 summarizes the results from several
experiments; the maximal reduction caused by Rut was 12.31 ± 3.30%.
|
|
Effects of Rut on NO Production.
The average basal NO content
in cultured ECs was 65.6 ± 5.6 pmol/106
cells. Rut (1.0 and 10.0 µM) significantly stimulated NO production in ECs in HBSS containing Ca2+ in a
concentration-dependent manner (Fig.
11). The vehicle itself did not
significantly alter the basal NO in ECs. Rut in
Ca2+-free, EGTA-added HBSS had no effect on NO
production (Fig. 11).
|
| |
Discussion |
|---|
|
|
|---|
Previous studies have indicated that Rut exerts hypotensive
effects in the rat and dilates isolated aortic ring. The actions are
largely endothelium dependent and likely involve
Ca2+ fluxes, mobilization, and NO release (Wang
et al., 1996
). Using patch-clamping techniques and cultured cells, the
present study focused on Rut's cellular actions in ECs and VMSCs.
With K+ and Na+ channels
blocked, whole-cell patch-clamp studies in isolated cultured ECs
indicated Rut elicited macroscopic ionic currents. Such
Ca2+ currents, induced by 0.1 and 1.0 µM Rut,
were relevant to the concentration-dependent vasorelaxing effects of
Rut on endothelium-intact aortic rings. These inward
Ca2+ current measurements also corroborated
previous spectrofluorometric observations (Wang et al., 1996
),
indicating that the augmentation in inward Ca2+
currents correlated with exaggerated Ca2+ entry.
Taken together, these observations suggested that Rut modulated
Ca2+ fluxes directly through some Rut-sensitive
mechanisms in the Ca2+ channels. However, there
was a conspicuous temporal discrepancy between Rut-induced membrane
activation, as reflected by the rise in Ca2+
currents, and increase in
[Ca2+]i. Several
possibilities might help to explain such a temporal lapse. First,
patch-clamp measurements represent only changes in the
Ca2+ currents per se. The rapid development of
the Rut-induced inward Ca2+ currents might
reflect the opening of the Ca2+ channel, whereas
the subsequent decay might reflect the kinetics of drug and action site
interactions and inner kinetics of Ca2+ channels
themselves. Second, Ca2+ channel opening may just
trigger off a cascade of intracellular events leading eventually to
increase in [Ca2+]i, a
process that may take much longer to complete. Finally, a finite time
is needed for the penetration of Rut from the edge of the confluent ECs
to those cells in the optical recording field used in the
fura-2/AM studies.
The fact that the NO inhibitors L-NNA and hydroquinone readily blocked Rut-induced endothelium-dependent relaxation in the rat aorta suggested that NO was likely the mediator responsible. Examination using a sensitive chemiluminescence NO detection method in this study indicated that Rut increased NO production in a Ca2+-dependent manner. Together, with a concomitant elevation in cGMP production, these observations were consistent with the notion that a rise in [Ca2+]i led to enhancement of the NO-cGMP vasorelaxing axis.
Patch-clamping studies in isolated VMSCs indicated again Rut directly
inhibited Ca2+-generated currents in the L-type
VDCCs, the predominant Ca2+ channels in VMSCs.
However, Rut also inhibited NE-induced contraction, suggesting that it
also attenuated Ca2+ influx through ROCCs. Thus,
it seems that suppression of both VDCCs and ROCCs in VSMCs are
involved. Therefore, in addition to inhibition of
Ca2+ release from intracellular stores previously
reported (Wang et al., 1996
), it seems that Rut can also suppress
membrane VDCCs and ROCCs in VSMCs.
The possibility of activation of K+ channels was examined with several types of antagonists including 4-aminopyridine, apamin, charybdotoxin, and glibenclamide. The failure of any of these antagonists to inhibit Rut's actions precluded the involvement of K+ channels.
Figure 12 summarizes the major findings
of this study. In essence, the proposed Rut-induced vasodilatory and
hypotensive mechanisms consisted of major endothelial
Ca2+-NO-cGMP actions as well as minor direct
inhibition of membrane Ca2+ channel and
intracellular Ca2+ release in VSMCs.
|
| |
Acknowledgments |
|---|
We thank Dr. Andrew Yau-Chik Shum of the Department and Institute of Pharmacology, The National Yang-Ming University, and Dr. Alan Maydwell for proofreading and editing the manuscript.
| |
Footnotes |
|---|
Accepted for publication January 28, 1999.
Received for publication June 29, 1998.
1 This work was supported by Grants NSC87-2314-B077-001 from the National Science Council of the Republic of China (to C.F.C.).
Send reprint requests to: Prof. Chieh-Fu Chen, National Research Institute of Chinese Medicine, No. 155-1, Section 2, Li-Nong Street, Pei-tou District (112), Taipei, Taiwan, Republic of China. E-mail: jennyw{at}cma23.nricm.edu.tw
| |
Abbreviations |
|---|
Rut, rutaecarpine;
EC, endothelial cell;
VSMC, vascular smooth muscle cell;
NO, nitric oxide;
L-NNA, N
-nitro-L-arginine;
NE, norepinephrine;
VDCC, voltage-dependent Ca2+ channel;
KCa, Ca2+-dependent K+;
Kv, voltage-dependent K+;
MAP, mean arterial pressure;
FCS, fetal calf serum;
HBSS, Hanks' balanced salt solution;
ROCC, receptor-operated Ca2+ channel;
I-V, current voltage.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Wu and Z. Hu Rutaecarpine Induces Chloride Secretion across Rat Isolated Distal Colon J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 256 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-J. Wang, A. Y.-C. Shum, Y.-L. Lin, J.-F. Liao, X.-C. Wu, J. Ren, and C.-F. Chen Calcium Channel Blockade in Vascular Smooth Muscle Cells: Major Hypotensive Mechanism of S-Petasin, a Hypotensive Sesquiterpene from Petasites formosanus J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 240 - 246. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||